Hospital M&A activity slowed quite a bit in the first half of 2025, with deal volume and transacted revenue falling sharply amid economic uncertainty and sweeping policy changes. While traditional ...

Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive ...

Samsung announced plans to acquire Xealth, a startup that helps hospitals integrate digital tools into clinical workflows, as part of its broader push into U.S. healthcare. The deal reflects growing ...

Digital health funding held steady in the first half of 2025, with AI-focused startups capturing the majority of capital and driving rapid adoption among providers. The digital health space also saw ...

The Trump administration's healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the ...

Rural hospitals are facing growing cybersecurity threats and digital demands but often lack the resources to respond — a gap ...

June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health ...

Some hospitals are turning to AI to help manage declining revenue and financial pressure, but one expert says success depends on more than just buying new tech. Prashant Karamchandani of Chartis ...

Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows hospitals to "buy low and sell high" by purchasing discounted medications and charging insured ...

BioCryst Pharmaceuticals is selling the European rights and assets for its top product for $250 million, cash that the rare disease drug developer will use to pay off debt. The buyer is privately ...

Through the convergence of proactive policy, advanced technology and strategic public-private partnerships, we can achieve this “no wrong door” vision and deliver a connected, streamlined ...